Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Herpes / November 2003

Tip: Looking for answers? Try searching our database.

Viroxyn new treatment

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Perl Molson - 19 Nov 2003 11:34 GMT
"Unlike acyclovir treatments, which interrupt the genetic code of
herpes and eventually cause the virus to stop growing, Viroxyn strips
the lipid coating off the virus and kills it on contact in the
affected area."

What do you think of this, folks?

Perl Molson

A Totally New and Effective Approach to Treating Cold Sores and Fever
Blisters

Do you suffer from cold sores/fever blisters? You're not alone.
Roughly one hundred fifty million people in the United States
experience recurrent cold sores.
What most people don't realize is that cold sores are actually a
highly contagious herpes simplex virus infection (usually HSV-1, or
oral herpes) on the lips. But now there is an innovative new way to
treat cold sores and fever blisters.

If you have a cold sore, treat it with Viroxyn®. Viroxyn® provides
rapid relief from the pain, itching and burning associated with cold
sores/fever blisters, and has shown to greatly reduce healing time. In
many people, Viroxyn® eliminates the pain within minutes of
application.

http://viroxyndirect.com/ViroxynDirect.cfm
Tim Fitzmaurice - 19 Nov 2003 11:42 GMT
> "Unlike acyclovir treatments, which interrupt the genetic code of
> herpes and eventually cause the virus to stop growing, Viroxyn strips
> the lipid coating off the virus and kills it on contact in the
> affected area."
>
> What do you think of this, folks?

Well it tells you very little beause this is essentially what soap does.
If they are getting FDA listings then there's more to the story than this
soundbite tells you. Its fine for a press release but not a lot of help
for us with the comparative familiarity with the field. Nothing about
time, specificity or anything we'd want to know.

The healing time they quote IS interesting. Suggests that the med may be
doing more than just targeting virus...which is the next step for lesion
treatment - deal with the cold sore, not just the viral activity. That
could be good or merely OK dependant on exactly whats going on. Doesn't
seem to suggest anywhere in the press release (and remember it IS just a
press release) anything on transmission or asymptomatic issues has been
studied.

Tim
--
When playing rugby, its not the winning that counts, but the taking apart
ICQ: 5178568
Perl Molson - 20 Nov 2003 15:20 GMT
> > "Unlike acyclovir treatments, which interrupt the genetic code of
> > herpes and eventually cause the virus to stop growing, Viroxyn strips
[quoted text clipped - 18 lines]
>
> Tim

Like soap, huh?
C'mon, you can be that gealous on the product!

They were talking about the protein envelope that is targeted in virus
or something like that.

P.S. Man, you didn't aswered, do the viruses multiply
in the neurons and in the skin's cells or both or only in the skin's cells?

Thanks for answering to my question.

Perl Molson
Tim Fitzmaurice - 20 Nov 2003 15:33 GMT
> > > "Unlike acyclovir treatments, which interrupt the genetic code of
> > > herpes and eventually cause the virus to stop growing, Viroxyn strips
[quoted text clipped - 21 lines]
> Like soap, huh?
> C'mon, you can be that gealous on the product!

Im not in the slightest bit jealous, please don;t ascribe this sort of
motive to what I say, its both insulting and innaccurate - I said the
press release doesn;t tell you enough. Of what they said in the release
there isn't anything to give you more info than what is essentially the
basic action of detergents. There is presumably more going on and I;d need
more detail to comment sensibly. ie as I explcitly said...there is enough
info for a press release, not enough for the sort of details we discuss
over here.

> They were talking about the protein envelope that is targeted in virus
> or something like that.

No they said the LIPID coat...thats the bit of membrane around the protein
capsid. Envelope viruses can have that stripped fairly easily by
detergents, which does a pretty good job of deactivating them. There are a
lot more details needed on whats going on ie where does it strip, when,
how, whats the active compoud, how does it get to the site of the virus
etc.

> P.S. Man, you didn't aswered, do the viruses multiply
> in the neurons and in the skin's cells or both or only in the skin's cells?

There are several replies yet to come, Im a bit busty at the moment...the
short answer to the above is it is both, but the details differ slightly
and presumably the different webpages will be focusing on the specifics
the aspects of the virus they are loooking at.

Tim
--
When playing rugby, its not the winning that counts, but the taking apart
ICQ: 5178568
Perl Molson - 20 Nov 2003 23:01 GMT
> > > > "Unlike acyclovir treatments, which interrupt the genetic code of
> > > > herpes and eventually cause the virus to stop growing, Viroxyn strips
[quoted text clipped - 30 lines]
> info for a press release, not enough for the sort of details we discuss
> over here.

Please don't get me wrong, here,
I am just trying to underestand some things, I am not
here to insult anyone!
Sorry for the false impression that I've presented in here.

> > They were talking about the protein envelope that is targeted in virus
> > or something like that.
[quoted text clipped - 15 lines]
>
> Tim

Ok, I am looking forward to your replies, when you have more spare time.

Perl Molson
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.